Drugs / Stromal Vascular Fraction
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03792360 | Feb 2021 → Feb 2027 | esophageal atresia/tracheoesophageal fistula | Mayo Clinic | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stromal Vascular Fraction | “SVF (Stromal Vascular Fraction)” NCT03792360 ↗ |
| Known as | SVF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03792360 ↗ |
| Modality | Cell therapy | “human cell therapy” NCT03792360 ↗ |